Pacific Biosciences of California Inc. (Nasdaq: PACB) narrowed losses more than expected for the first quarter to 23 cents per share from 27 cents per share last year. The stock price soared $1.73 to close at $10.72.
Pacific Biosciences narrows losses
April 22, 2016 at 19:57 PM EDT
